Lord Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 05-07-2024
- Paid Up Capital ₹ 0.90 M
as on 05-07-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.10 Cr
as on 05-07-2024
- Satisfied Charges ₹ 9.00 M
as on 05-07-2024
- Revenue 187.17%
(FY 2022)
- Profit 9.63%
(FY 2022)
- Ebitda 33.66%
(FY 2022)
- Net Worth 21.79%
(FY 2022)
- Total Assets 52.31%
(FY 2022)
About Lord Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹4.10 Cr. The company has closed loans amounting to ₹9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mahalakshmi Krishnamurthy and Manoj Mehta serve as directors at the Company.
- CIN/LLPIN
U17100MH2010PTC204901
- Company No.
204901
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lord Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahalakshmi Krishnamurthy  | Director | 24-Dec-2019 | Current |
| Manoj Mehta | Director | 25-Oct-2010 | Current |
Financial Performance and Corporate Structure Insights of Lord Lifescience.
Lord Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 187.17% increase. The company also saw a slight improvement in profitability, with a 9.63% increase in profit. The company's net worth Soared by an impressive increase of 21.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lord Lifescience?
In 2021, Lord Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Haba International Private LimitedActive 10 months 26 daysMahalakshmi Krishnamurthy is a mutual person
- Sunline Gas Technologies Private LimitedActive 24 years 10 months
Mahalakshmi Krishnamurthy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jul 2020 | ₹2.50 M | Open |
Others Creation Date: 27 Jan 2016 | ₹1.50 Cr | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 27 Jan 2016 | ₹6.00 M | Open |
How Many Employees Work at Lord Lifescience?
Unlock and access historical data on people associated with Lord Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lord Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lord Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
